Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
8.75
+0.63 (7.76%)
At close: Apr 28, 2026, 4:00 PM EDT
8.79
+0.04 (0.46%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $285.12 million as of April 28, 2026. Its market cap has increased by 297.13% in one year.
Market Cap
285.12M
Enterprise Value
172.07M
1-Year Change
297.13%
Ranking
Category
Stock Price
$8.75
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $285.12M, a decrease of -19.64%. That is a compound annual growth rate of -7.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 264.59M | 37.43% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 202.76M |
| Replimune Group | 199.83M |
| Karyopharm Therapeutics | 195.23M |
| Canton Strategic Holdings | 193.20M |
| Whitehawk Therapeutics | 190.20M |
| Korro Bio | 185.91M |
| Acumen Pharmaceuticals | 185.59M |
| Unicycive Therapeutics | 183.98M |